Pledpharma: Interview with Nicklas Westerholm and Peder Walberg (video)
Redeye met with Nicklas Westerholm, CEO of Pledpharma, and Peder Walberg, CEO of Rare Thyroid Therapeutics, to discuss the two companies’ announced combination and focus on Orphan indications.